Details about Valentin Brodszky

Access statistics for papers by Valentin Brodszky.

Last updated 2024-10-15. Update your information in the RePEc Author Service.

Short-id: pbr554

Working Papers

2023

1. Development of an instrument for the assessment of health-related multi-sectoral resource use in Europe: the PECUNIA RUM
   LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library
   See also Journal Article Development of an Instrument for the Assessment of Health-Related Multi-sectoral Resource Use in Europe: The PECUNIA RUM, Applied Health Economics and Health Policy, Springer (2023) (2023)
2. International comparability of reference unit costs of education services: when harmonizing methodology is not enough (PECUNIA project)
   LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library

2015

3. The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries?
   Corvinus Economics Working Papers (CEWP), Corvinus University of Budapest View citations (1)
   See also Journal Article The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries?, Society and Economy, Akadémiai Kiadó, Hungary (2015) View citations (1) (2015)
4. Trading between perceived risks and benefits related to biosimilar biological treatment in Crohn’s disease; discrete choice experiment among gastroenterologists
   Corvinus Economics Working Papers (CEWP), Corvinus University of Budapest

Journal Articles

2024

1. Population Norms for the EQ-5D-5L, PROPr and SF-6D in Hungary
   PharmacoEconomics, 2024, 42, (5), 583-603
2. Psychometric properties and general population reference values for PROMIS Global Health in Hungary
   The European Journal of Health Economics, 2024, 25, (4), 549-562
3. The Development of a New Approach for the Harmonized Multi-Sectoral and Multi-Country Cost Valuation of Services: The PECUNIA Reference Unit Cost (RUC) Templates
   Applied Health Economics and Health Policy, 2024, 22, (6), 783-796

2023

4. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis
   The European Journal of Health Economics, 2023, 24, (1), 139-152 View citations (2)
5. Development of an Instrument for the Assessment of Health-Related Multi-sectoral Resource Use in Europe: The PECUNIA RUM
   Applied Health Economics and Health Policy, 2023, 21, (2), 155-166
   See also Working Paper Development of an instrument for the assessment of health-related multi-sectoral resource use in Europe: the PECUNIA RUM, LSE Research Online Documents on Economics (2023) (2023)

2022

6. In Search for Comparability: The PECUNIA Reference Unit Costs for Health and Social Care Services in Europe
   IJERPH, 2022, 19, (6), 1-15 View citations (1)
7. Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?
   Applied Health Economics and Health Policy, 2022, 20, (3), 291-303
8. Value Set for the EQ-5D-Y-3L in Hungary
   PharmacoEconomics, 2022, 40, (2), 205-215 View citations (6)

2019

9. A comparison of European, Polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases
   The European Journal of Health Economics, 2019, 20, (1), 119-132 View citations (1)
10. Cost-of-illness studies in nine Central and Eastern European countries
    The European Journal of Health Economics, 2019, 20, (1), 155-172 View citations (2)
11. Determinants of the acceptability of health problems in different ages: exploring a new application of the EQ VAS
    The European Journal of Health Economics, 2019, 20, (1), 31-41 View citations (2)
12. EQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature review
    The European Journal of Health Economics, 2019, 20, (1), 109-117 View citations (1)
13. Is the trend of increasing use of patient-reported outcome measures in medical device studies the sign of shift towards value-based purchasing in Europe?
    The European Journal of Health Economics, 2019, 20, (1), 133-140 View citations (2)
14. Patient and general population values for luminal and perianal fistulising Crohn’s disease health states
    The European Journal of Health Economics, 2019, 20, (1), 91-100
15. Subjective expectations regarding ageing: a cross-sectional online population survey in Hungary
    The European Journal of Health Economics, 2019, 20, (1), 17-30 View citations (1)
16. Subjective well-being in patients with pemphigus: a path analysis
    The European Journal of Health Economics, 2019, 20, (1), 101-107
17. Towards a Central-Eastern European EQ-5D-3L population norm: comparing data from Hungarian, Polish and Slovenian population studies
    The European Journal of Health Economics, 2019, 20, (1), 141-154
18. Validity and reliability of the 9-item Shared Decision Making Questionnaire (SDM-Q-9) in a national survey in Hungary
    The European Journal of Health Economics, 2019, 20, (1), 43-55 View citations (2)

2017

19. Exploring the Relationship between Quality of Life (EQ-5D) and Clinical Measures in Adult Attention Deficit Hyperactivity Disorder (ADHD)
    Applied Research in Quality of Life, 2017, 12, (2), 409-424

2016

20. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe
    The European Journal of Health Economics, 2016, 17, (1), 31-42 View citations (14)
21. Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe
    The European Journal of Health Economics, 2016, 17, (1), 89-98 View citations (5)

2015

22. The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries?
    Society and Economy, 2015, 37, (1), 73-88 View citations (1)
    See also Working Paper The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries?, Corvinus Economics Working Papers (CEWP) (2015) View citations (1) (2015)

2014

23. Acceptability of less than perfect health states in rheumatoid arthritis: the patients’ perspective
    The European Journal of Health Economics, 2014, 15, (1), 73-82 View citations (5)
24. Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries
    The European Journal of Health Economics, 2014, 15, (1), 35-43 View citations (7)
25. Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries
    The European Journal of Health Economics, 2014, 15, (1), 65-71
26. Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis
    The European Journal of Health Economics, 2014, 15, (1), 45-52
27. Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres
    The European Journal of Health Economics, 2014, 15, (1), 101-109 View citations (6)
28. Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison
    The European Journal of Health Economics, 2014, 15, (1), 53-64 View citations (2)
29. Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary
    The European Journal of Health Economics, 2014, 15, (1), 111-119 View citations (2)
30. Quality of Life and Costs in Parkinson's Disease: A Cross Sectional Study in Hungary
    PLOS ONE, 2014, 9, (9), 1-7 View citations (4)
31. Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists
    The European Journal of Health Economics, 2014, 15, (1), 83-92 View citations (2)
32. Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries
    The European Journal of Health Economics, 2014, 15, (1), 27-34 View citations (2)

2010

33. The disease burden of colorectal cancer in Hungary
    The European Journal of Health Economics, 2010, 10, (1), 35-40 View citations (2)